Chadalavada P, Afraz S, AlGhadir-AlKhalaileh M, Suarez Z, Swartz A, Rashid M
Crohns Colitis 360. 2024; 6(2):otae025.
PMID: 38711857
PMC: 11071514.
DOI: 10.1093/crocol/otae025.
Murray A, Nguyen T, Parker C, Feagan B, MacDonald J
Cochrane Database Syst Rev. 2020; 8:CD000544.
PMID: 32856298
PMC: 8094989.
DOI: 10.1002/14651858.CD000544.pub5.
Murray A, Nguyen T, Parker C, Feagan B, MacDonald J
Cochrane Database Syst Rev. 2020; 8:CD000543.
PMID: 32786164
PMC: 8189994.
DOI: 10.1002/14651858.CD000543.pub5.
Liu C, Ji S, Ding Y, Zhou L, Liu X, Li W
Ir J Med Sci. 2018; 187(4):935-942.
PMID: 29392650
DOI: 10.1007/s11845-018-1752-y.
Wang Y, Parker C, Feagan B, MacDonald J
Cochrane Database Syst Rev. 2016; (5):CD000544.
PMID: 27158764
PMC: 7045447.
DOI: 10.1002/14651858.CD000544.pub4.
Budesonide for the treatment of ulcerative colitis.
Abdalla M, Herfarth H
Expert Opin Pharmacother. 2016; 17(11):1549-59.
PMID: 27157244
PMC: 4989907.
DOI: 10.1080/14656566.2016.1183648.
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y, Parker C, Bhanji T, Feagan B, MacDonald J
Cochrane Database Syst Rev. 2016; 4:CD000543.
PMID: 27101467
PMC: 7045743.
DOI: 10.1002/14651858.CD000543.pub4.
The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing.
Yoshino T, Yamakawa K, Nishimura S, Watanabe K, Yazumi S
Intest Res. 2016; 14(1):37-42.
PMID: 26884733
PMC: 4754520.
DOI: 10.5217/ir.2016.14.1.37.
Relationship Between Cytomegalovirus Infection and Steroid Resistance in Inflammatory Bowel Disease: A Meta-Analysis.
Wu X, Wu L, Ji H, Wang F
Dig Dis Sci. 2015; 60(11):3203-8.
PMID: 26031424
PMC: 4621704.
DOI: 10.1007/s10620-015-3733-6.
Intestinal epithelium-specific knockout of the cytochrome P450 reductase gene exacerbates dextran sulfate sodium-induced colitis.
Zhu Y, Xie F, Ding L, Fan X, Ding X, Zhang Q
J Pharmacol Exp Ther. 2015; 354(1):10-7.
PMID: 25926522
PMC: 4468430.
DOI: 10.1124/jpet.115.223263.
Ulcerative colitis: an overview.
Archambault A
Can Fam Physician. 2011; 36:343-51.
PMID: 21234051
PMC: 2280645.
New pathophysiological insights and modern treatment of IBD.
Engel M, Neurath M
J Gastroenterol. 2010; 45(6):571-83.
PMID: 20213337
DOI: 10.1007/s00535-010-0219-3.
Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.
Jinno Y, Ohtani H, Nakamura S, Oki M, Maeda K, Fukushima K
Virchows Arch. 2006; 448(4):412-21.
PMID: 16435133
DOI: 10.1007/s00428-005-0136-7.
Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M
World J Gastroenterol. 2005; 11(20):3085-90.
PMID: 15918195
PMC: 4305845.
DOI: 10.3748/wjg.v11.i20.3085.
STEROID ADDICTION IN ULCERATIVE COLITIS.
Kelly M
Br Med J. 1964; 2(5423):1528-9.
PMID: 14214199
PMC: 1817169.
DOI: 10.1136/bmj.2.5423.1528-c.
THE CONTROLLED THERAPEUTIC TRIAL IN GASTROENTEROLOGY.
TRUELOVE S, Wright R
Am J Dig Dis. 1964; 9:1-30.
PMID: 14102685
DOI: 10.1007/BF02232676.
Some notes on the epidemiology of nonspecific ulcerative colitis. An apparent increase in incidence in Jews.
Weiner H, Lewis C
Am J Dig Dis. 1960; 5:406-18.
PMID: 13843571
DOI: 10.1007/BF02232626.
Clinical and pathologic observations in steroid-treated ulcerative colitis.
Spiro H
Am J Dig Dis. 1960; 5:548-63.
PMID: 13833385
DOI: 10.1007/BF02233056.
Ulcerative colitis provoked by milk.
TRUELOVE S
Br Med J. 1961; 1(5220):154-60.
PMID: 13778258
PMC: 1952962.
DOI: 10.1136/bmj.1.5220.154.
Factors in the pathogenesis of peptic ulcer. The present basis of treatment.
Lennard-Jones J
Postgrad Med J. 1960; 36:722-32.
PMID: 13760842
PMC: 2482049.
DOI: 10.1136/pgmj.36.422.722.
